Seasoned operator and investor specializing in growth-stage technology and consumer businesses. Megan Claucherty is an experienced executive with operating leadership, go-to-market scaling, and board roles; background spans product-led growth, commercial strategy, and post-investment value creation. Prior roles include senior operating positions and advisory work with venture and growth equity firms. Market-focused profile useful for LPs, corporate investors and portfolio companies seeking commercial scale expertise.
Seasoned operator and investor specializing in growth-stage technology and consumer businesses. Megan Claucherty is an experienced executive with operating leadership, go-to-market scaling, and board roles; background spans product-led growth, commercial strategy, and post-investment value creation. Prior roles include senior operating positions and advisory work with venture and growth equity firms. Market-focused profile useful for LPs, corporate investors and portfolio companies seeking commercial scale expertise.
Focuses on growth-stage technology and consumer investments, prioritizing companies with clear product-market fit and repeatable revenue models. Prefers revenue-led, unit-economics-driven underwriting and commits as an active, operator-investor to commercial value creation. Capital allocation emphasizes staged commitments with follow-on reserves for scaling leaders; time horizon typically mid-term growth (3–7 years). Risk discipline centers on customer retention, CAC payback and scalable go-to-market motion. Sector focus: SaaS, marketplaces, consumer tech; edge: hands-on go-to-market and board-level scaling execution.
Focuses on growth-stage technology and consumer investments, prioritizing companies with clear product-market fit and repeatable revenue models. Prefers revenue-led, unit-economics-driven underwriting and commits as an active, operator-investor to commercial value creation. Capital allocation emphasizes staged commitments with follow-on reserves for scaling leaders; time horizon typically mid-term growth (3–7 years). Risk discipline centers on customer retention, CAC payback and scalable go-to-market motion. Sector focus: SaaS, marketplaces, consumer tech; edge: hands-on go-to-market and board-level scaling execution.
| Trades 741 | Longs Won 443/741 59% | Profit Factor 3.54 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $10.31M |
| Average Win $5.84M | Best Trade (Aug 14) $133.74M | Sharpe Ratio -16.75 |
| Average Loss -$2.45M | Worst Trade (Sep 30) -$81.89M | Z-Score 0.47 (36.38%) |
| Commissions $0 | Avg. Trade Length 8m 4w | Expectancy $2.51M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 1,422 | 1,280 | 1,138 | 996 | 853 | 711 | 569 | 427 | 284 | 142 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
ABX Abacus Global Management, Inc. | 158,200 | $1.3M | $1.63M | - | $329,052.31 | 25.27% | -1.528% |
ACAD Acadia Pharmaceuticals Inc. | 53,497 | $888,585 | $1.38M | - | $495,382.39 | 55.75% | -2.561% |
ADP Automatic Data Processing Inc. | 10,619 | $3.24M | $2.83M | - | -$414,884.37 | -12.79% | +0.982% |
AFRM Affirm Holdings, Inc. | 562,889 | $22.19M | $40.25M | - | $18.07M | 81.43% | -2.375% |
AGIO Agios Pharmaceuticals Inc. | 50,692 | $1.49M | $1.52M | - | $36,497.84 | 2.46% | -8.336% |
AJG Arthur J. Gallagher & Co. | 6,780 | $1.92M | $1.69M | - | -$233,435.43 | -12.13% | -2.745% |
ALGM Allegro MicroSystems, Inc. | 1.66M | $41.61M | $68.72M | - | $27.11M | 65.14% | +0.121% |
ALLY Ally Financial Inc. | 303,175 | $11.06M | $13.14M | - | $2.08M | 18.81% | -0.345% |
ALNY Alnylam Pharmaceuticals Inc | 21,159 | $5.71M | $4.35M | - | -$1.36M | -23.89% | +0.019% |
AMAT Applied Materials, Inc. | 195,034 | $28.3M | $99.01M | - | $70.71M | 249.83% | +1.176% |
AMBA Ambarella, Inc. | 904,536 | $53.93M | $77.79M | - | $23.86M | 44.24% | +16.075% |
AMPL Amplitude, Inc. | 138,316 | $1.41M | $1.23M | - | -$181,193.92 | -12.86% | +3.136% |
AMTM Amentum Holdings, Inc. | 65,540 | $1.19M | $1.45M | - | $262,160 | 21.98% | +2.163% |
AMZN Amazon.com Inc | 199,140 | $40.69M | $54.08M | - | $13.39M | 32.91% | +15.321% |
BANC Banc of California Inc. | 205,185 | $2.91M | $3.93M | - | $1.02M | 34.95% | +1.645% |
BCRX BioCryst Pharmaceuticals Inc. | 468,799 | $3.52M | $4.21M | - | $693,822 | 19.73% | -2.814% |
BFH Bread Financial Holdings Inc. | 62,551 | $3.82M | $6.76M | - | $2.94M | 76.99% | -2.305% |
BKU BankUnited, Inc. | 493,194 | $16.99M | $23.01M | - | $6.02M | 35.45% | +1.237% |
BMRN Biomarin Pharmaceutical Inc. | 56,540 | $4M | $3.39M | - | -$603,282.2 | -15.09% | -0.924% |
CACI Caci International Inc. | 63,464 | $23.29M | $31.59M | - | $8.3M | 35.66% | +4.274% |